Market Capitalization (Millions $) |
292 |
Shares
Outstanding (Millions) |
127 |
Employees |
- |
Revenues (TTM) (Millions $) |
- |
Net Income (TTM) (Millions $) |
-41 |
Cash Flow (TTM) (Millions $) |
14 |
Capital Exp. (TTM) (Millions $) |
0 |
Compass Therapeutics Inc
Compass Therapeutics Inc is a biotechnology company focused on developing targeted antibody therapies to treat cancer. The company combines computational biology, antibody drug discovery, and translational medicine to create differentiated antibody therapeutics. Compass Therapeutics aims to develop multi-specific antibodies that can simultaneously target multiple disease-associated antigens, potentially leading to more effective and safer treatments. The company's goal is to address the limitations of traditional monoclonal antibody therapies by utilizing their unique approach to drug discovery and development.
Company Address: 80 Guest St., Suite 601 Boston 2135 MA
Company Phone Number: 500-8099 Stock Exchange / Ticker: NASDAQ CMPX
|